The Latin America, Middle East and Africa Urology Laser Market would witness market growth of 7.25% CAGR during the forecast period (2019-2025).
The use of lasers in the treatment of urolithiasis, urinary strictures, and bladder tumors has made it safe to treat older patients with several comorbidities without further need to change the treatment with anticoagulant medications. Furthermore, laser procedures are less invasive, minimize hospitalization time and allow for a shorter time for bladder catheterization, sometimes even removing the need for bladder catheterization. More stable performance and a lower number of reoperations are also characterized by these procedures. There are also expectations that laser equipment will become a necessary and indispensable asset in all urology wards due to increased competition among laser manufacturers, decreased purchase and maintenance expenses, as well as increased operational safety.
Due to its advantages over Transurethral Resection Prostate (TURP), a traditional method, the thulium laser segment is expected to record the highest CAGR during the estimation period. Thulium laser is considered to be the most effective treatment method for BPH as it provides many advantages. These advantages range from lower bleeding rate to quick and secure procedures involving fewer incisions. Consequently, thulium laser has overcome the demerits of the TURP procedure, which causes significant blood loss, thereby increasing the demand for the product.
Holmium laser is commonly used in prostate surgeries that prefer a minimally invasive procedure to remove tissues that block urine flow through the prostate. Due to its safety and efficacy in treating patients without an incision procedure, the market for holmium systems is growing. Depending on the size of the prostate, the procedure takes between 45-90 minutes. Because this is a less invasive procedure, on the same day the patients can get discharged.
Based on Laser Type, the market is segmented into Holmium Laser System, Thulium laser system, Diode Laser System and Other Laser Type. Based on Application, the market is segmented into Benign Prostatic Hyperplasia (BPH), Urolithiasis, Non-Muscle-Invasive Bladder Cancer (NMIBC) and Other Application. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Olympus Corporation, Johnson and Johnson (Ethicon, Inc.), Stryker Corporation, Boston Scientific Corporation, Richard Wolf GmbH, Cook Medical, Inc. (Cook Group), Karl Storz SE & Co. KG, Lumenis Ltd. (XIO Group), Allengers Medical Systems Limited, and Becton, Dickinson and Company
Scope of the Study
Market Segmentation:
By Laser Type

  • Holmium Laser System
  • Thulium laser system
  • Diode Laser System
  • Other Laser Type


By Application

  • Benign Prostatic Hyperplasia (BPH)
  • Urolithiasis
  • Non-Muscle-Invasive Bladder Cancer (NMIBC)
  • Other Application


By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA


Companies Profiled

  • Olympus Corporation
  • Johnson and Johnson (Ethicon, Inc.)
  • Stryker Corporation
  • Boston Scientific Corporation
  • Richard Wolf GmbH
  • Cook Medical, Inc. (Cook Group)
  • Karl Storz SE & Co. KG
  • Lumenis Ltd. (XIO Group)
  • Allengers Medical Systems Limited
  • Becton, Dickinson and Company


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free